搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Medpage Today on MSN
13 小时
MEK Inhibitor Scores Big Win in Adults, Children With Neurofibromatosis Type 1
Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor ...
15 分钟
on MSN
5 of the top sources of foodborne illness and how to prevent it
Amid the ongoing McDonald's E. coli investigation, Fox News Digital spoke with several food safety experts about the most ...
LancasterOnline
14 小时
'Walking pneumonia' cases are on the rise in Lancaster County, surrounding region
Walking pneumonia cases are on the rise in Lancaster County and across the region, and an expert says more very young ...
4 小时
on MSN
HEALTH WARNING: Uptick in cases of walking pneumonia and whooping cough reported in DC ...
This spike has raised concerns among health professionals.
15 小时
MD, NoVA Seeing Dramatic Spike In Walking Pneumonia Cases: Reports
Healthcare centers across D.C., Maryland and Northern Virginia recorded a more than 300% increase in cases since this time ...
17 小时
Global Measles Cases Up 20% In A Year, With Poor Vaccination To Blame
Young children are particularly vulnerable to the disease, which killed an estimated 107,500 people in 2023, most of whom ...
The Canadian Press on MSN
11 小时
Montreal children’s hospitals over capacity, ask parents not to come unless urgent
Montreal pediatric hospitals are surging over capacity and asking parents to avoid the emergency department unless their ...
Cure Today
11 小时
FDA Approves Revuforj for Relapsed/Refractory Acute Leukemia Subset
Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.
MedPage Today
10 小时
FDA Approves First Menin Inhibitor for Acute Leukemia
The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransferase 2A gene ( ...
manilatimes
17 小时
Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with ...
No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...
CTV News
19 小时
Montreal children's hospitals urging parents to avoid ERs
The two biggest children’s hospitals in Montreal - the CHU Sainte-Justine and Montreal Children's Hospital - are asking ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈